Effects of tranexamic acid on coagulation indexes of patients undergoing heart valve replacement surgery under cardiopulmonary bypass.
This study aims to explore the effects of tranexamic acid on the coagulation indexes of patients undergoing heart valve replacement surgery under the condition of cardiopulmonary bypass (CPB). One hundred patients who conformed to the inclusive criteria were selected and divided into a tranexamic acid group and a non-tranexamic acid group. They all underwent heart valve replacement surgery under CPB. Patients in the tranexamic acid group were intravenously injected with 1 g of tranexamic acid (100 mL) at the time point after anesthesia induction and before skin incision and at the time point after the neutralization of heparin. Patients in the non-tranexamic acid group were given 100 mL of normal saline at corresponding time points, respectively. Then the coagulation indexes of the two groups were analyzed. The activated blood clotting time (ACT) of the two groups was within normal scope before CPB, while four coagulation indexes including prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), and fibrinogen (FIB) had significant increases after surgery; the PT and INR of the tranexamic acid group had a remarkable decline after surgery. All the findings suggest that the application of tranexamic acid in heart valve replacement surgery under CPB can effectively reduce intraoperative and postoperative blood loss.
Department of Cardiology of Xuanwu Hospital of Capital Medical University, Beijing, China.
Fei
F
Liu
Department of Cardiology of Xuanwu Hospital of Capital Medical University, Beijing, China.
Dong
D
Xu
Department of Cardiology of Xuanwu Hospital of Capital Medical University, Beijing, China.
Kefeng
K
Zhang
Department of Cardiology of Xuanwu Hospital of Capital Medical University, Beijing, China zhangjianzjjj@163.com.
Jian
J
Zhang
D000293:Adolescent; D001777:Blood Coagulation / Q000187:drug effects*; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D006348:Cardiac Surgical Procedures / Q000379:methods; D002315:Cardiopulmonary Bypass / Q000379:methods; D005260:Female; D006351:Heart Valves / Q000601:surgery*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D019106:Postoperative Hemorrhage / Q000517:prevention & control*; D014148:Tranexamic Acid / Q000627:therapeutic use*
D014148:Tranexamic Acid; D006493:Heparin
blood loss; cardiopulmonary bypass; coagulation index; heart valve replacement; tranexamic acid
N Engl J Med. 2010 Apr 29;362(17):1575-85
20228401
J Bone Joint Surg Am. 2013 Nov 6;95(21):1969-74
24196467
Anesthesiology. 2008 Nov;109(5):856-63
18946298
J Pharmacol Exp Ther. 2002 Apr;301(1):168-73
11907171
J Vet Emerg Crit Care (San Antonio). 2012 Apr;22(2):225-9
22487300
J Immunol. 2002 Feb 1;168(3):1219-25
11801658
Crit Care. 2014 Dec 04;18(6):656
25475406
J Vasc Surg. 2014 May;59(5):1203-8
24440679
Neth Heart J. 2015 Jan;23(1):28-32
25326103
Am J Emerg Med. 2013 Jul;31(7):1012-6
23688570
J Clin Pharmacol. 2006 Feb;46(2):229-34
16432275
N Engl J Med. 2003 Apr 17;348(16):1517-26
12700371